Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy

Allen, W L, Dunne, P D, McDade, S, Scanlon, E, Loughrey, M, Coleman, H G, McCann, C, McLaughlin, K, Nemeth, Z, Syed, N A, Jithesh, P V, Arthur, K, Wilson, R, Coyle, V M, McArt, D, Murray, G L, Samuel, L, Nuciforo, P, Jimenez, J, Argiles, G, Dienstmann, R, Tabernero, J, Picariello, L, Messerini, L, Nobili, S, Mini, E, Sheahan, K, Ryan, E, Johnston, P G, Van Schaeybroeck, S, Lawler, M & Longley, D B 2018, 'Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy', JCO Precision Oncology, vol. 2, pp. 1-15. https://doi.org/10.1200/PO.17.00241